EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Microbial Influences on Immune Checkpoint Inhibitor Response in Melanoma: The Interplay between Skin and Gut Microbiota

Youssef Bouferraa iD, Callie Fares, Maroun Bou Zerdan iD, Lucy Boyce Kennedy iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24119702 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Youssef Bouferraa und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Cleveland Clinic Foundation, Cleveland, OH 44195, USA. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Melanoma, Microbiota. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunotherapy has revolutionized the treatment of melanoma, but its limitations due to resistance and variable patient responses have become apparent. The microbiota, which refers to the complex ecosystem of microorganisms that inhabit the human body, has emerged as a promising area of research for its potential role in melanoma development and treatment response. Recent studies have highlighted the role of microbiota in influencing the immune system and its response to melanoma, as well as its influence on the development of immune-related adverse events associated with immunotherapy. In this article, we discuss the complex multifactorial mechanisms through which skin and gut microbiota can affect the development of melanoma including microbial metabolites, intra-tumor microbes, UV light, and the immune system. In addition, we will discuss the pre-clinical and clinical studies that have demonstrated the influence of different microbial profiles on response to immunotherapy. Additionally, we will explore the role of microbiota in the development of immune-mediated adverse events.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeMelanomaMicrobiotaHumansImmune Checkpoint InhibitorsImmunotherapy

Stichwörter der Autor:innen

gut microbiotaimmune checkpoint inhibitorsimmune-related adverse eventsmelanomaskin microbiota

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Internal Medicine, Cleveland Clinic Foundation, Cleveland, OH 44195, USA.
  • Faculty of Medicine, American University of Beirut, Beirut 2020, Lebanon.
  • Department of Internal Medicine, SUNY Upstate Medical University, New York, NY 13205, USA.
  • Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH 44195, USA.

ORCID-Profile: Youssef Bouferraa, Maroun Bou Zerdan, Lucy Boyce Kennedy

Zitieren

APA

Bouferraa, Y., Fares, C., Bou Zerdan, M., & Boyce Kennedy, L. (2023). Microbial Influences on Immune Checkpoint Inhibitor Response in Melanoma: The Interplay between Skin and Gut Microbiota. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24119702

Vancouver

Bouferraa Y, Fares C, Bou Zerdan M, Boyce Kennedy L. Microbial Influences on Immune Checkpoint Inhibitor Response in Melanoma: The Interplay between Skin and Gut Microbiota. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24119702

BibTeX
@article{Bouferraa2023,
  author = {Bouferraa, Youssef and Fares, Callie and Bou Zerdan, Maroun and Boyce Kennedy, Lucy},
  title = {Microbial Influences on Immune Checkpoint Inhibitor Response in Melanoma: The Interplay between Skin and Gut Microbiota},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24119702}
}
Kostenlos starten →